about
Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancerING1 and 5-azacytidine act synergistically to block breast cancer cell growthUp-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group studyThymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells.Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples.A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.Exploiting drug repositioning for discovery of a novel HIV combination therapyBiological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiationGene body methylation can alter gene expression and is a therapeutic target in cancer.Epigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer.Hypermethylation of the human proton-coupled folate transporter (SLC46A1) minimal transcriptional regulatory region in an antifolate-resistant HeLa cell line.Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy.Decitabine inhibits the cell growth of cholangiocarcinoma in cultured cell lines and mouse xenografts.Cancer epigenetics: linking basic biology to clinical medicine.Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors.Palliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An in vitro and clinical study.Validation of a novel statistical model for assessing the synergy of combined-agent cancer chemoprevention.Hypermethylation of MAPK13 Promoter in Oesophageal Squamous Cell Carcinoma Is Associated with Loss of p38δ MAPK Expression.Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia.Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion.Functional DNA demethylation is accompanied by chromatin accessibility.Loss of imprinting of IGF2 and the epigenetic progenitor model of cancerSimultaneous quantitative determination of 5-aza-2'-deoxycytidine genomic incorporation and DNA demethylation by liquid chromatography tandem mass spectrometry as exposure-response measures of nucleoside analog DNA methyltransferase inhibitorsThe use of hypomethylating agents in the treatment of hematologic malignancies.DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes.DNA polymerases as therapeutic targetsCombination treatment with decitabine and ionizing radiation enhances tumor cells susceptibility of T cellsTargeting DNA methylation.Array-based DNA methylation profiling in follicular lymphoma.Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors.Deoxyuridine analog nucleotides in deoxycytidine analog treatment: secondary active metabolites?Promoter hypermethylation in prostate cancer.Epigenetic aberrations during oncogenesis.Epigenetic regulation in myelodysplastic syndromes: implications for therapy.Epigenetics, development, and cancer: zebrafish make their mark..PAX2 in human kidney malformations and disease.The role of decitabine for the treatment of acute myeloid leukemia.Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.
P2860
Q24642847-71A7A743-5B9D-47C9-B781-F28EFCBF0257Q27322757-5A6D92D5-06ED-4E65-BAF1-73E59FD479FCQ33278623-826739B1-B672-4E0D-BE4C-46597DEE3C3EQ33390459-8D16823B-4447-4466-A739-C344717A387BQ33798412-9F7DED11-DEC1-40D9-87CC-107E28E64A58Q33891538-F38D7826-C643-4102-9681-6483AF731C1EQ33901844-1A40BD3D-F1EA-4819-BDA8-854E89EF57E4Q34124794-BF2E06DF-5B36-4F35-A7D9-E3F2B59950EAQ34405013-5276B487-43F6-407D-A316-744208133DA5Q34471361-8CACF5BC-08F3-4693-B235-D7E53954F9DCQ34897761-D74CF20F-21B7-4388-8E09-573A80DBE412Q34996747-B4F64760-BBED-4D16-A54D-40E7FCEF57B6Q35170918-09F84441-09A9-40B9-B338-4D52383427F2Q35212176-19D2837B-18B6-4F98-91CF-34BDE11DE929Q35311768-D7DECCBB-3A55-4C85-A8CD-0270EE3C64F6Q35348043-94BA48E7-BB18-4D4F-9C00-4BA645D588AAQ35593084-21D6E962-857B-49E1-80D3-4FEE243BA29BQ35948096-3268D28A-8871-4F0B-9D91-18D8F4CBA9BFQ36394885-A3197818-68E0-4CDC-95B2-05001CCBB26BQ36416114-63EB5723-9EE6-409B-85B0-7FE0731B720CQ36445921-10D6FD6A-26BF-4ACF-9452-1608622BDD8EQ36609590-8AD4DA32-C9CA-4AD2-A2A3-2874E74DCC04Q36769429-9EAA86EF-4918-4CC9-85A5-11688E28753AQ36813932-D927D5C0-8773-4554-B2D1-1EC19D8140B1Q36900856-455B655C-34FD-41FE-AA14-EEA27A48666FQ36929658-F257B1EA-3DBA-43D4-9D31-0379FA80A0A8Q37052250-C1F68A4A-4A85-4C9D-9A55-9B21BA5067C4Q37216862-0129CA69-6604-45D0-A685-12EE42111B19Q37285301-4F20E17E-AFA8-45FF-A386-082BE7E954D3Q37320354-767A8841-BA37-44B9-9AC6-A4BC68E1AD14Q37388672-72F390A1-AC76-49B0-B188-FBADCB0103CCQ37493954-9DC06BE9-A604-4C5C-9D5C-042BCA790C14Q37701947-8256ACE4-0663-4598-A0DA-5D6A6E514907Q37791396-C9F07E08-EB31-46B1-9E56-21CB22B9CD68Q37830385-8B1E6D3E-4562-4740-B8D4-E006364381F1Q37850456-B2D287DA-CEAB-4336-8DED-B5982BBB40B9Q37889228-843E461F-ED4C-4C2B-A961-F81C5D4F0F03Q37964437-30D37856-873C-4440-A92E-84F1C917A887Q38056891-3EA5FBAF-0ED3-4DF2-9A08-ABD6633F0580Q38155455-4941243B-60F2-4D7B-AFD4-9B36C09A72F3
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Decitabine--bedside to bench.
@ast
Decitabine--bedside to bench.
@en
Decitabine--bedside to bench.
@nl
type
label
Decitabine--bedside to bench.
@ast
Decitabine--bedside to bench.
@en
Decitabine--bedside to bench.
@nl
prefLabel
Decitabine--bedside to bench.
@ast
Decitabine--bedside to bench.
@en
Decitabine--bedside to bench.
@nl
P2093
P1476
Decitabine--bedside to bench.
@en
P2093
Etsuko Aoki
Jean-Pierre J Issa
Yasuhiro Oki
P304
P356
10.1016/J.CRITREVONC.2006.07.010
P577
2006-10-04T00:00:00Z